Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - the SPECTRA Study
NCT ID: NCT06774053
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
600 participants
OBSERVATIONAL
2025-01-30
2045-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question is:
What are the key factors influencing the well-being and health outcomes of transgender and gender-diverse individuals undergoing gender-affirming therapies?
Researchers will compare health outcomes across different subgroups, such as those at different stages of transition or detransition, to examine the effects of gender-affirming therapies.
Participants will:
Complete electronic questionnaires assessing gender congruence, quality of life, mental health, and other outcomes.
Provide biological samples (e.g., blood, urine, stool, and skin swabs) for laboratory analysis.
Undergo clinical evaluations related to endocrinology, fertility, dermatology, and urology as part of their routine follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opportunities and Limitations of Swiss Polytrauma Registry Data for Scientific Purposes- Registry Data for Scientific Purposes
NCT03999346
Uronephrological Complications Risk Factors in Spinal Dysraphism
NCT05718440
Complications of Bladder Augmentation in Children
NCT06733194
Prospective Cohort of Transitional Urology Patients
NCT03061084
Complications of Enterocystoplasty in Children
NCT05840874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort of Transgender and Gender Diverse individuals in Switzerland
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Established diagnosis of gender incongruence
* Indication for gender affirming therapy or ongoing or discontinued gender affirming therapy
Exclusion Criteria
* Missing commitment or ability to study protocol adherence
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Luzern
OTHER
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bettina Winzeler
PD Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Basel
Basel, , Switzerland
Cantonal Hospital of Lucerne
Lucerne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-00018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.